Saturday, June 25, 2022

Two-Pronged Approach for Medical Marijuana Inc (OTCMKTS:MJNA)

Medical Marijuana Inc (OTCMKTS:MJNA) is a penny stock player in the MMJ space that has become increasingly central in the zeitgeist for OTC traders. The stock has become a mainstay on the top of the “most traded” list on the daily basis for all OTC stocks so far in 2017, and a number of catalysts are serving to stoke the flames. Most recently, the company announced that its subsidiary, Kannaway LLC, “the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products”, is holding an exclusive Red Carpet Event in Atlanta, Ga., over the weekend.

That announcement piles on to the company’s recent notice that its CEO was featured in a series of interviews on Phoenix TV, one of China’s largest TV networks, outlining the history and the various benefits of the Company’s products. In both cases, we are talking about exposure. There are two prongs to the “great race to get ahead in the cannabis game” right now: investment and exposure. We like to see investment most, but exposure is branding, and the battle for public awareness is an institutionalization process, and cannot be overlooked.

Medical Marijuana Inc (OTCMKTS:MJNA) trumpets itself as an investment holding company that operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high-value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.

The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products.

In addition, MJNA provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products.

Medical Marijuana Inc. is the first publicly held company vested in the medical marijuana and industrial hemp markets.

According to company materials, “The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented and proprietary based cannabinoid products, to seed and stalk or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 85 proprietary and patented cannabinoid delivery methods that are more socially and medically acceptable than typical industry methods. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.”

Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March 2011. The company was incorporated in 2003 and is headquartered in Poway, California.

Find out when $MJNA stock reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

In terms of recent action, the stock has seen 35% piled on for shareholders of the name during the trailing month. Market participants may want to pay attention to this stock. Furthermore, the listing has seen an influx in interest of late, with the stock’s recent average trading volume running exceeding 100% over what the stock has registered over the longer term. The float is huge in this name, so that added attention isn’t a major swing factor, but it does illustrate the point we made at the outset.

As far as the race for exposure, the company’s introduction to Chinese awareness is probably the more important point to consider. The interviews on Phoenix TV in China, which were broadcast on Dec. 23 and Dec. 30 of 2016, summarized the personal experiences of CEO Dr. Stuart Titus and also detailed the disruptive nature and enormous economic potential for Medical Marijuana, Inc.’s cannabidiol (CBD) products. The broadcast also showcased the Company’s major sales subsidiary HempMeds and flagship product Real Scientific Hemp Oil (RSHO).

According to the recent release, the Phoenix TV segments discussed developments such as athletes preferring cannabis to pharmaceutical treatments currently on the market – and also laid out the vast economic opportunities that CBD products have brought to the ever-expanding cannabis industry.

“If you extrapolate Colorado to California where we have a much larger population, we believe that this now-legal market is going to represent about $35 billion, so this will be the largest cannabis market in the world,” Phoenix TV quoted Titus as saying. “Not only will this add to our national GDP, it’s going to improve employment with tremendous job creation.”

At this time, carrying a capital value in the market of $103M, MJNA has a chunk ($406K) of cash on the books, which compares with about $3.9M in total current liabilities. One should also note that debt has been growing over recent quarters. MJNA is pulling in trailing 12-month revenues of $7M. In addition, the company is seeing major top line growth, with y/y quarterly revenues growing at 18.6%. This will almost certainly continue to be a very interesting story and we will look forward to updating it again soon. For continuing coverage on shares of $MJNA stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!

Related Articles


  1. I heard Dr. Titus speak at a cannabis conference in Los Angeles back in 2015 and was really impressed with what he was doing with marijuana and also industrial hemp. I hope things go well for him and his company because we need major changes with our policy on both marijuana and hemp.


Please enter your comment!
Please enter your name here

Stay Connected


Latest Articles